These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 26208824)
21. Lessons to be learned from varicella-zoster virus. Rentier B; Piette J; Baudoux L; Debrus S; Defechereux P; Merville MP; Sadzot-Delvaux C; Schoonbroodt S Vet Microbiol; 1996 Nov; 53(1-2):55-66. PubMed ID: 9010998 [TBL] [Abstract][Full Text] [Related]
22. Latency of varicella zoster virus; a persistently perplexing state. Kinchington PR Front Biosci; 1999 Feb; 4():D200-11. PubMed ID: 9989948 [TBL] [Abstract][Full Text] [Related]
23. T-cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection. Schaap A; Fortin JF; Sommer M; Zerboni L; Stamatis S; Ku CC; Nolan GP; Arvin AM J Virol; 2005 Oct; 79(20):12921-33. PubMed ID: 16188994 [TBL] [Abstract][Full Text] [Related]
24. Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model. Arvin AM Herpes; 2006 Nov; 13(3):75-80. PubMed ID: 17147912 [TBL] [Abstract][Full Text] [Related]
25. Varicella zoster virus: out of Africa and into the research laboratory. Grose C Herpes; 2006 Aug; 13(2):32-6. PubMed ID: 16895651 [TBL] [Abstract][Full Text] [Related]
27. Manipulation of the Innate Immune Response by Varicella Zoster Virus. Gerada C; Campbell TM; Kennedy JJ; McSharry BP; Steain M; Slobedman B; Abendroth A Front Immunol; 2020; 11():1. PubMed ID: 32038653 [TBL] [Abstract][Full Text] [Related]
28. The C-terminus of varicella-zoster virus glycoprotein M contains trafficking motifs that mediate skin virulence in the SCID-human model of VZV pathogenesis. Zerboni L; Sung P; Sommer M; Arvin A Virology; 2018 Oct; 523():110-120. PubMed ID: 30119012 [TBL] [Abstract][Full Text] [Related]
29. Varicella-zoster virus ORF4 latency-associated protein is important for establishment of latency. Cohen JI; Krogmann T; Ross JP; Pesnicak L; Prikhod'ko EA J Virol; 2005 Jun; 79(11):6969-75. PubMed ID: 15890936 [TBL] [Abstract][Full Text] [Related]
30. Immune evasion as a pathogenic mechanism of varicella zoster virus. Abendroth A; Arvin AM Semin Immunol; 2001 Feb; 13(1):27-39. PubMed ID: 11289797 [TBL] [Abstract][Full Text] [Related]
31. Varicella-zoster virus infection of a human CD4-positive T-cell line. Zerboni L; Sommer M; Ware CF; Arvin AM Virology; 2000 May; 270(2):278-85. PubMed ID: 10792986 [TBL] [Abstract][Full Text] [Related]
32. Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis. Zerboni L; Berarducci B; Rajamani J; Jones CD; Zehnder JL; Arvin A J Virol; 2011 Jan; 85(1):98-111. PubMed ID: 20962081 [TBL] [Abstract][Full Text] [Related]
33. Current In Vivo Models of Varicella-Zoster Virus Neurotropism. Mahalingam R; Gershon A; Gershon M; Cohen JI; Arvin A; Zerboni L; Zhu H; Gray W; Messaoudi I; Traina-Dorge V Viruses; 2019 May; 11(6):. PubMed ID: 31159224 [TBL] [Abstract][Full Text] [Related]
34. Varicella-zoster virus and virus DNA in the blood and oropharynx of people with latent or active varicella-zoster virus infections. Levin MJ J Clin Virol; 2014 Dec; 61(4):487-95. PubMed ID: 25453570 [TBL] [Abstract][Full Text] [Related]
35. Varicella-zoster virus latency in human ganglia. Kennedy PG Rev Med Virol; 2002; 12(5):327-34. PubMed ID: 12211045 [TBL] [Abstract][Full Text] [Related]
36. Memory cytotoxic T cell responses to viral tegument and regulatory proteins encoded by open reading frames 4, 10, 29, and 62 of varicella-zoster virus. Arvin AM; Sharp M; Moir M; Kinchington PR; Sadeghi-Zadeh M; Ruyechan WT; Hay J Viral Immunol; 2002; 15(3):507-16. PubMed ID: 12479399 [TBL] [Abstract][Full Text] [Related]
37. Varicella-zoster virus glycoprotein I is essential for spread in dorsal root ganglia and facilitates axonal localization of structural virion components in neuronal cultures. Christensen J; Steain M; Slobedman B; Abendroth A J Virol; 2013 Dec; 87(24):13719-28. PubMed ID: 24109230 [TBL] [Abstract][Full Text] [Related]
38. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model. Zerboni L; Hinchliffe S; Sommer MH; Ito H; Besser J; Stamatis S; Cheng J; Distefano D; Kraiouchkine N; Shaw A; Arvin AM Virology; 2005 Feb; 332(1):337-46. PubMed ID: 15661165 [TBL] [Abstract][Full Text] [Related]
39. Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo. Che X; Zerboni L; Sommer MH; Arvin AM J Virol; 2006 Apr; 80(7):3238-48. PubMed ID: 16537591 [TBL] [Abstract][Full Text] [Related]
40. Discordant varicella-zoster virus glycoprotein C expression and localization between cultured cells and human skin vesicles. Storlie J; Carpenter JE; Jackson W; Grose C Virology; 2008 Dec; 382(2):171-81. PubMed ID: 18954885 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]